Novartis India Ltd share price logo

Novartis India Ltd Share Price (500672)

₹1030.30.39%

bell
Get free price alerts. Set up your Free investment account to get Live Prices. >
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Novartis India Ltd share Performance

  • ₹1021.6
    ₹1058.65
    ₹1030.3
    downward going graph

    0.84%

    Low

    Day's Volatility:3.60%

    High

    2.75%

    downward going graph
  • ₹561.05
    ₹1224
    ₹1030.3
    downward going graph

    45.54%

    Low

    52 Weeks Volatility:64.35%

    High

    18.80%

    downward going graph
1 Month Return4.8 %
3 Month Return18.6 %
1 Year Return76.36 %
Previous Close₹1,034.35
Open₹1,026.00
Volume23.39K
Upper Circuit-
Lower Circuit-
Market Cap₹1,659.84Cr

Company Information

Novartis India Limited (NIL) is a subsidiary of the world's second-largest pharmaceutical company, Swiss giant Novartis. Incorporated in 1947, the company has four core segments- Pharmaceuticals, Generics, Over the Counter, and Animal Health. Its history traces back to the middle of the 18th century when Geigy was founded, followed by Ciba in 1860 and then Sandoz in 1886. It was only in 1996 when the three separate entities merged to become Novartis. In 2000, the company acquired products from SmithKline Beecham and started a Joint Effort to Eradicate Tuberculosis (JEET) in India. The Glivec drug was launched in India in 2002 for which they were awarded TERI's Corporate Social Responsibility award. Over the years the company has alligned with various global organisations inlcuding the WHO to help stem the spread of malaria, as well as launching numerous initiatives including the Arogya Parivar in 2008 to target healthcare needs of villagers. Moreover, between 2000 and 2006, it spent over USD 755 million on research for neglected diseases and patient-access programs.

Share Price: ₹1030.30 per share as on 18 Apr, 2024 04:01 PM
Market Capitalisation: ₹1,659.84Cr as of today
Listing date: 08 Nov, 1994
Chairperson Name: C Snook
OrganisationNovartis India Ltd
HeadquartersMumbai
IndustryTrading
E-voting on sharesClick here to vote

Key events for Novartis India Ltd

  • Novartis Considers Selling Listed Unit in India - 22 Mar, 2024

    Swiss pharmaceutical giant, Novartis, is exploring the sale of its listed unit, Novartis India Limited, while continuing to expand research and development operations in India through its unlisted unit, Novartis Healthcare Private Limited.

  • Novartis Plans to Sell Stake in Novartis India Limited - 21 Mar, 2024

    Novartis CEO Narasimhan has announced that the company plans to sell its 70.6% stake in Novartis India Limited (NIL) to a new owner, while continuing to build on capacity and operations in India through NHPL.

  • Novartis India to Launch Novel CML Treatment Asciminib - 15 Mar, 2024

    Novartis India is set to launch a first-of-its-kind treatment for chronic myeloid leukemia (CML) called Asciminib by the end of March. The company is currently in talks with potential distribution partners, but has not disclosed any specific details about brand partnerships.

  • Novartis India in Discussions for Distribution Partner for Asciminib Launch - 14 Mar, 2024

    Novartis India is in talks to secure a distribution partner for the launch of Asciminib, a first-in-class treatment for chronic myeloid leukemia. The drug targets the ABL myristoyl pocket and is expected to be launched soon.

Fundamentals of Novartis India Ltd

Insights on Novartis India Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NOVARTIND stock has moved up by 18.6%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 28.47% to 28.59% in Dec 2023 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NOVARTIND has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.68% of holdings in Dec 2023 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 140.0% return, outperforming this stock by 61.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.32% to 0.19% in Dec 2023 quarter

Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
70.68%
0.00
Foreign Institutions
0.19%
-39.17
Mutual Funds
0%
0.00
Retail Investors
28.59%
0.44
Others
0.53%
0.06

Technicals of Novartis India Ltd share

News & Events of Novartis India Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Novartis India Ltd shares.

Novartis India Ltd (500672) share price today is ₹1030.3

Novartis India Ltd is not listed on NSE

Novartis India Ltd is listed on BSE

  • Today’s highest price of Novartis India Ltd is ₹1058.65.
  • Today’s lowest price of Novartis India Ltd is ₹1021.6.

Today’s traded volume of Novartis India Ltd(500672) is 23.39K.

Today’s market capitalisation of Novartis India Ltd(500672) is ₹1659.84Cr.

Novartis India Ltd(500672Price
52 Week High
₹1224
52 Week Low
₹561.05

Novartis India Ltd(500672) share price is ₹1030.3. It is down -15.83% from its 52 Week High price of ₹1224

Novartis India Ltd(500672) share price is ₹1030.3. It is up 83.64% from its 52 Week Low price of ₹561.05

Novartis India Ltd(500672Returns
1 Day Returns
-4.05%
1 Month Returns
4.8%
3 Month Returns
18.6%
1 Year Returns
76.36%